Cyanide toxicokinetics: the behavior of cyanide, thiocyanate and 2-amino-2-thiazoline-4-carboxylic acid in multiple animal models.
Cyanide causes toxic effects by inhibiting cytochrome c oxidase, resulting in cellular hypoxia and cytotoxic anoxia, and can eventually lead to death. Cyanide exposure can be verified by direct analysis of cyanide concentrations or analyzing its metabolites, including thiocyanate (SCN(-)) and 2-amino-2-thiazoline-4-carboxylic acid (ATCA) in blood. To determine the behavior of these markers following cyanide exposure, a toxicokinetics study was performed in three animal models: (i) rats (250-300 g), (ii) rabbits (3.5-4.2 kg) and (iii) swine (47-54 kg). Cyanide reached a maximum in blood and declined rapidly in each animal model as it was absorbed, distributed, metabolized and eliminated. Thiocyanate concentrations rose more slowly as cyanide was enzymatically converted to SCN(-). Concentrations of ATCA did not rise significantly above the baseline in the rat model, but rose quickly in rabbits (up to a 40-fold increase) and swine (up to a 3-fold increase) and then fell rapidly, generally following the relative behavior of cyanide. Rats were administered cyanide subcutaneously and the apparent half-life (t1/2) was determined to be 1,510 min. Rabbits were administered cyanide intravenously and the t1/2 was determined to be 177 min. Swine were administered cyanide intravenously and the t1/2 was determined to be 26.9 min. The SCN(-) t1/2 in rats was 3,010 min, but was not calculated in rabbits and swine because SCN(-) concentrations did not reach a maximum. The t1/2 of ATCA was 40.7 and 13.9 min in rabbits and swine, respectively, while it could not be determined in rats with confidence. The current study suggests that cyanide exposure may be verified shortly after exposure by determining significantly elevated cyanide and SCN(-) in each animal model and ATCA may be used when the ATCA detoxification pathway is significant.
1Department of Chemistry and Biochemistry, South Dakota State University, Avera Health Science Center (SAV) 131, PO Box 2202, Brookings, SD 57007, USA.
Raj K
RK
Bhandari
Robert P
RP
Oda
Ilona
I
Petrikovics
David E
DE
Thompson
Matthew
M
Brenner
Sari B
SB
Mahon
Vikhyat S
VS
Bebarta
Gary A
GA
Rockwood
Brian A
BA
Logue
D000818:Animals; D015415:Biomarkers / Q000097:blood; D003486:Cyanides / Q000097:blood / Q000378:metabolism / Q000493:pharmacokinetics*; D006207:Half-Life; D008658:Inactivation, Metabolic; D007275:Injections, Intravenous; D007279:Injections, Subcutaneous; D008297:Male; D011817:Rabbits; D017207:Rats, Sprague-Dawley; D013045:Species Specificity; D034421:Sus scrofa; D013844:Thiazoles / Q000097:blood*; D013861:Thiocyanates / Q000097:blood*; D066007:Toxicokinetics
D015415:Biomarkers; D003486:Cyanides; D013844:Thiazoles; D013861:Thiocyanates; C015674:2-amino-delta(2)-thiazoline-4-carboxylic acid; C031760:thiocyanate